Transcode Therapeutics

RNAZ NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $753 $0 $0 $0
Gross Profit 612 -138 -137
EBITDA -3,918 -5,161 -4,204
EBIT -4,059 -5,300 -4,341
Net Income -4,087 -4,087 -5,299 -4,341
Net Change In Cash 753 0 0 0
Free Cash Flow -5,627 -5,663 -3,510 -4,409
Cash 2,767 2,767 7,452 3,572
Basic Shares 179 627 78 32

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $0 $0 $0 $0
Gross Profit -516 -98 -42
EBITDA -18,901 -17,466 -5,829 -726
EBIT -19,418 -18,665 -6,151 -726
Net Income -18,546 -35,129 -6,938 -2,738
Net Change In Cash 0 0 0 0
Free Cash Flow -18,110 -15,863 -5,521 -492
Cash 2,767 4,968 20,825 828
Basic Shares 179 16 16 7

Earnings Calls

Quarter EPS
2024-03-31 -$22.84
2023-12-31 -$22.84
2023-09-30 -$1.68
2023-06-30 -$3.29